28 Jun 2017

Gen-Plus is a small medium-sized, privately owned company. Its aim is to discover innovations for contract partners. We design formulation and technology concepts for the pharmaceutical industry. This includes solid and semisolid dosage forms as well as patches and thin films. The range is from the early idea to the medicinal product samples (for clinical trials) under GMP conditions. Another competence of us is consulting services for the pharmaceutical industry.

In addition to NCE formulations for Big Pharma, Gen-Plus creates innovative design-arounds and Generics-plus concepts for established APIs. There is also substantial number of OTC- and dietary supplement-projects in the pipeline. Recently, Gen-Plus  has started to work on biotech molecules (non-parenteral) and liposomes.

In our laboratory (area approximately 1000 m²) are currently 15 staff members working in formulation and analytics. Special equipment allows handling of high potent active pharmaceutical ingredients. In addition, Gen-Plus has a comprehensive quality management system and is licensed for handling of narcotics.

We have continuously invested in new technology e.g. Hot Melt Extrusion, Lyophilization, Amorphization of APIs, Micro-/Nanoemulsions etc. 

Recent innovations include alternative technologies based on Laser and 2D-/3D-Printing Technology respectively.

Gen-Plus is closely linked to numerous national and international CROs and universities. Thus, we offer to our customer access to the latest technologies for scientific cooperation-projects.

We look forward to finding - in close cooperation with you - solutions for your complex challenges. Get in touch with our innovative team and our broad-based laboratory. 

You will get inspired by many opportunities for innovation! 

Content provided by our supplier

Gen-Plus GmbH & Co KG

  • DE
  • 2017
    On CPHI since
  • 25 - 49
Company types
Contract Service

Other Content from Gen-Plus GmbH & Co KG ()